Form 8-K - Current report:
SEC Accession No. 0001140361-23-005120
Filing Date
2023-02-08
Accepted
2023-02-08 07:22:10
Documents
14
Period of Report
2023-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10047718_8k.htm   iXBRL 8-K 29823
2 EXHIBIT 99.1 brhc10047718_ex99-1.htm EX-99.1 15323
6 image0.jpg GRAPHIC 6839
  Complete submission text file 0001140361-23-005120.txt   195076

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20230208.xsd EX-101.SCH 3880
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20230208_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20230208_pre.xml EX-101.PRE 16054
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10047718_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 23597073
SIC: 2836 Biological Products, (No Diagnostic Substances)